News / Blog
Delivery and Holidays in September
Catalog
Levofloxacin intravenous infusion 500 mg for bacterial infections
Product Code :
Availability : 7
USD 539.00
General information on Levofloxacin intravenous infusion 500 mg for bacterial infections
Package details: 10 bags
Manufacturer: Daiichi Sankyo Espha Co., Ltd., Japan
Active ingredient: levofloxacin hydrate (chemical formula C18H20FN3O4)
Medical effect: Levofloxacin is effective for treatment of the following diseases and conditions:
- pneumonia,
- respiratory tract infections,
- urinary tract infections,
- abdominal infections,
- bacterial skin infections,
- endocarditis,
- meningitis,
- pelvic inflammatory disease,
- tuberculosis.
Contraindications and precautions: do not use in pregnant and breastfeeding women. Do not use in children or elderly people (over 65 years old). Do not use in patients with epilepsy or other seizure disorders. If an allergic reaction occurs, stop using the product and consult with your doctor.
Dosage and administration of Japanese Levofloxacin intravenous infusion 500 mg for bacterial infections. Take 1 intravenous infusion within 60 minutes once a day. The consulting doctor may adjust the dosage according to age and symptoms.
How effective is Levofloxacin intravenous infusion 500 mg from Japan for bacterial infections?
Levofloxacin is a quinolone antibiotic designed for treatment of various bacterial infections. Is effective against more than 800 strains of respiratory, urinary tract, gastrointestinal, abdominal and other bacterial infections. It stops bacterial growth and destroys bacterial DNA, resulting in fast killing of the bacteria.
Who should use Levofloxacin intravenous infusion 500 mg from Japan?
First, levofloxacin is recommended for patients with respiratory tract infections and pneumonia. It is especially effective against the important respiratory pathogen Streptococcus pneumoniae. Secondly, levofloxacin is effective to all existing members of Enterobacteriaceae (N. Yamane, R. N. Jones et al. Levofloxacin in vitro activity: results from an international comparative study with ofloxacin and ciprofloxacin". Journal of Chemotherapy, 1994, April. 6 (2): 83–91). That’s why it’s widely used for the treatment of bacterial abdominal infections.